ArticleNeurology and therapyPublished
Cost Per Relapse Avoided for Ozanimod Versus Other Selected Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis in the United States
Regional connection
Verified Author affiliations on the Europe PMC record name Bristol Myers Squibb, University of Pennsylvania. Affiliation source
- Institutions
- Bristol Myers Squibb, University of Pennsylvania
- County
- Philadelphia County
Publication record
- Type
- Article
- Venue
- Neurology and therapy
- Published
- Topic
- Clinical care
- Subject terms
- Cost-effectiveness Analysis; Relapsing–remitting Multiple Sclerosis; Disease-modifying Therapies; Ozanimod
- PubMed ID
- 37000386
- PubMed Central ID
- PMC10195930
- Open access
- Yes, open
- Added to directory
- Source checked